Polyethyleneimine-modified pectin beads for colon-specific drug delivery: In vitro and in vivo implications

References

• Atyabi F, Majzoob S, Iman M, Salehi M, Dorkoosh F. In vitro evaluation and modification of pectinate gel beads containing trimethyl chitosan, as a multi-particulate system for delivery of water-soluble macromolecules to colon. Carbohydr Polym 2005; 61: 39–51
   Web of Science ®Google Scholar
• Basit AW. Advances in colonic drug delivery. Drugs 2005; 65: 1991–2007
   PubMed Web of Science ®Google Scholar
• Baur JA, Pearson KJ, Price NL, Jamieson HA, Lerin C, Kalra A, Prabhu VV, Allard JS, Lopez-Lluch G, Lewis K, et al. Resveratrol improves health and survival of mice on a high-calorie diet. Nature 2006; 444: 337–42
   PubMed Web of Science ®Google Scholar
• Baur JA, Sinclair DA. Therapeutic potential of resveratrol: the in vivo evidence. Nat Rev Drug Discov 2006; 5: 493–506
   PubMed Web of Science ®Google Scholar
• Bourgeois S, Laham A, Besnard M, Andremont A, Fattal E. In vitro and in vivo evaluation of pectin beads for the colon delivery of beta-lactamases. J Drug Target 2005; 13: 277–84
   PubMed Web of Science ®Google Scholar
• Bourgeois S, Tsapis N, Honnas H, Andremont A, Shakweh M, Besnard M, Fattal E. Colonic delivery of beta-lactamases does not affect amoxicillin pharmacokinetics in rats. J Pharm Sci 2008; 97: 1853–63
   PubMed Web of Science ®Google Scholar
• Das S, Lin HS, Ho PC, Ng KY. The impact of aqueous solubility and dose on the pharmacokinetic profiles of resveratrol. Pharm Res 2008; 25: 2593–600
   PubMed Web of Science ®Google Scholar
• Das S, Ng KY. Colon-specific delivery of resveratrol: Optimization of multi-particulate calcium-pectinate carrier. Int J Pharm 2010a; 385: 20–8
   PubMed Web of Science ®Google Scholar
• Das S, Ng KY. Resveratrol-loaded calcium-pectinate beads: Effects of formulation parameters on drug release and bead characteristics. J Pharm Sci 2010b; 99: 840–60
   PubMed Web of Science ®Google Scholar
• Fan LF, He W, Bai M, Du Q, Xiang B, Chang YZ, Cao DY. Biphasic drug release: Permeability and swelling of pectin/ethylcellulose films, and in vitro and in vivo correlation of film-coated pellets in dogs. Chem Pharm Bull 2008; 56: 1118–25
   PubMed Web of Science ®Google Scholar
• Friend DR. New oral delivery systems for treatment of inflammatory bowel disease. Adv Drug Deliv Rev 2005; 57: 247–65
   PubMed Web of Science ®Google Scholar
• Gescher AJ, Steward WP. Relationship between mechanisms, bioavailibility, and preclinical chemopreventive efficacy of resveratrol: A conundrum. Cancer Epidemiol Biomarkers Prev 2003; 12: 953–7
   PubMed Web of Science ®Google Scholar
• Kaldas MI, Walle UK, Walle T. Resveratrol transport and metabolism by human intestinal Caco-2 cells. J Pharm Pharmacol 2003; 55: 307–12
   PubMed Web of Science ®Google Scholar
• Kaur K, Kim K. Studies of chitosan/organic acid/Eudragit RS/RL-coated system for colonic delivery. Int J Pharm 2009; 366: 140–8
   PubMed Web of Science ®Google Scholar
• Krishnaiah YS, Satyanarayana V, Dinesh Kumar B, Karthikeyan RS, Bhaskar P. In vivo pharmacokinetics in human volunteers: Oral administered guar gum-based colon-targeted 5-fluorouracil tablets. Eur J Pharm Sci 2003; 19: 355–62
   PubMed Web of Science ®Google Scholar
• Liu L, Fishman ML, Kost J, Hicks KB. Pectin-based systems for colon-specific drug delivery via oral route. Biomaterials 2003; 24: 3333–43
   PubMed Web of Science ®Google Scholar
• Maestrelli F, Cirri M, Corti G, Mennini N, Mura P. Development of enteric-coated calcium pectinate microspheres intended for colonic drug delivery. Eur J Pharm Biopharm 2008a; 69: 508–18
   PubMed Web of Science ®Google Scholar
• Maestrelli F, Zerrouk N, Cirri M, Mennini N, Mura P. Microspheres for colonic delivery of ketoprofen-hydroxypropyl-beta-cyclodextrin complex. Eur J Pharm Sci 2008b; 34: 1–11
   PubMed Web of Science ®Google Scholar
• Maier-Salamon A, Hagenauer B, Wirth M, Gabor F, Szekeres T, Jager W. Increased transport of resveratrol across monolayers of the human intestinal Caco-2 cells is mediated by inhibition and saturation of metabolites. Pharm Res 2006; 23: 2107–15
   PubMed Web of Science ®Google Scholar
• Marier JF, Vachon P, Gritsas A, Zhang J, Moreau JP, Ducharme MP. Metabolism and disposition of resveratrol in rats: Extent of absorption, glucuronidation, and enterohepatic recirculation evidenced by a linked-rat model. J Pharmacol Exp Ther 2002; 302: 369–73
   PubMed Web of Science ®Google Scholar
• Martin AR, Villegas I, La Casa C, De La Lastra CA. Resveratrol, a polyphenol found in grapes, suppresses oxidative damage and stimulates apoptosis during early colonic inflammation in rats. Biochem Pharmacol 2004; 67: 1399–410
   PubMed Web of Science ®Google Scholar
• Martin AR, Villegas I, Sanchez-Hidalgo M, De La Lastra CA. The effects of resveratrol, a phytoalexin derived from red wines, on chronic inflammation induced in an experimentally induced colitis model. Br J Pharmacol 2006; 147: 873–85
   PubMed Web of Science ®Google Scholar
• Munjeri O, Hodza P, Osim EE, Musabayane CT. An investigation into the suitability of amidated pectin hydrogel beads as a delivery matrix for chloroquine. J Pharm Sci 1998; 87: 905–8
   PubMed Web of Science ®Google Scholar
• Musabayane CT, Munjeri O, Bwititi P, Osim EE. Orally administered, insulin-loaded amidated pectin hydrogel beads sustain plasma concentrations of insulin in streptozotocin-diabetic rats. J Endocrinol 2000; 164: 1–6
   PubMed Web of Science ®Google Scholar
• Rodriguez M, Vila-Jato JL, Torres D. Design of a new multiparticulate system for potential site-specific and controlled drug delivery to the colonic region. J Control Release 1998; 55: 67–77
   PubMed Web of Science ®Google Scholar
• Schneider Y, Duranton B, Gosse F, Schleiffer R, Seiler N, Raul F. Resveratrol inhibits intestinal tumorigenesis and modulates host-defense-related gene expression in an animal model of human familial adenomatous polyposis. Nutr Cancer 2001; 39: 102–7
   PubMed Web of Science ®Google Scholar
• Sriamornsak P. Effect of calcium concentration, hardening agent and drying condition on release characteristics of oral proteins from calcium pectinate gel beads. Eur J Pharm Sci 1999; 8: 221–7
   PubMed Web of Science ®Google Scholar
• Tessitore L, Davit A, Sarotto I, Caderni G. Resveratrol depresses the growth of colorectal aberrant crypt foci by affecting bax and p21(CIP) expression. Carcinogenesis 2000; 21: 1619–22
   PubMed Web of Science ®Google Scholar
• Walle T, Hsieh F, Delegge MH, Oatis Jr JE, Walle UK. High absorption but very low bioavailability of oral resveratrol in humans. Drug Metab Dispos 2004; 32: 1377–82
   PubMed Web of Science ®Google Scholar
• Wong TW, Nurjaya S. Drug release property of chitosan-pectinate beads and its changes under the influence of microwave. Eur J Pharm Biopharm 2008; 69: 176–88
   PubMed Web of Science ®Google Scholar
• Wu B, Deng D, Lu Y, Wu W. Biphasic release of indomethacin from HPMC/pectin/calcium matrix tablet: II. Influencing variables, stability and pharmacokinetics in dogs. Eur J Pharm Biopharm 2008; 69: 294–302
   PubMed Web of Science ®Google Scholar
• Zhao XL, Li KX, Zhao XF, Pang DH, Chen DW. Study on colon-specific 5-Fu pH-enzyme Di-dependent chitosan microspheres. Chem Pharm Bull 2008; 56: 963–8
   PubMed Web of Science ®Google Scholar